Efficacy of antihypertensive treatment for target organ protection in patients with masked hypertension (ANTI-MASK): a multicentre, double-blind, placebo-controlled trial

• Published in: EClinicalMedicine Vol. 74; p. 102736
• Main Authors: Huang, Jian-Feng, Zhang, Dong-Yan, An, De-Wei, Li, Ming-Xuan, Liu, Chang-Yuan, Feng, Ying-Qing, Zheng, Qi-Dong, Chen, Xin, Staessen, Jan A., Wang, Ji-Guang, Li, Yan, Zhang, Yi-Qing, Chang, Gui-Li, Hu, Zhe, Li, Xi-Da, Liu, Can, Huang, Jia-Yi, Yu, Yu-Ling, Wang, Yi-Yun, Zhang, Xue-Ning, Yu, Jing, Ma, Rui-Xin, Liu, Heng-Xia, Chen, Xiao-Ping, Meng, Qing-Tao, Zhang, Zhi-Peng, Dou, Yu, Zhu, Mei-Yu, Wang, Wen-Juan, Zhu, Li-Li, Zhang, Min, Jiang, Yi-Nong, Lu, Yan, Yu, Wei, Xu, Xiao-Ling, Dai, Qiu-Yan, Zhu, Yu-Feng, Zhang, Hui-Jie, Zhang, Yu, Zhang, Jin-Shun, Bu, Pei-Li, Liu, Ling-Xin, Mu, Jian-Jun, Xu, Jing-Tao, Liao, Yue-Yuan, Guo, Hao, Liang, Xin-Yue
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.08.2024; Elsevier
• Subjects: Ambulatory blood pressure monitoring; Antihypertensive treatment; Internal Medicine; Masked hypertension; Randomised clinical trial; Antihypertensive treatment; Randomised clinical trial; Masked hypertension; Ambulatory blood pressure monitoring

Masked hypertension is associated with target organ damage (TOD) and adverse health outcomes, but whether antihypertensive treatment improves TOD in patients with masked hypertension is unproven. In this multicentre, randomised, double-blind, placebo-controlled trial at 15 Chinese hospitals, untreat...